IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,198,795 | -10.2% | 42,366 | +3.7% | 0.00% | – |
| Q2 2023 | $2,449,606 | +26.5% | 40,854 | +4.3% | 0.00% | – |
| Q1 2023 | $1,936,367 | -53.2% | 39,166 | -45.9% | 0.00% | – |
| Q4 2022 | $4,135,292 | +884.6% | 72,460 | +709.5% | 0.00% | – |
| Q3 2022 | $420,000 | -5.0% | 8,951 | -24.4% | 0.00% | – |
| Q2 2022 | $442,000 | +104.6% | 11,834 | +87.4% | 0.00% | – |
| Q4 2021 | $216,000 | -6.1% | 6,316 | +1.9% | 0.00% | – |
| Q3 2021 | $230,000 | – | 6,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $28,523,073 | 25.19% |
| Velan Capital Investment Management LP | 200,000 | $9,888,000 | 8.43% |
| RTW INVESTMENTS, LP | 5,649,943 | $279,333,182 | 5.82% |
| Paradigm Biocapital Advisors LP | 1,126,256 | $55,682,097 | 5.28% |
| Rock Springs Capital Management LP | 3,001,662 | $148,402,169 | 3.54% |
| Logos Global Management LP | 500,000 | $24,720,000 | 3.54% |
| TANG CAPITAL MANAGEMENT LLC | 405,600 | $20,052,864 | 2.99% |
| GREAT POINT PARTNERS LLC | 255,367 | $12,625,344 | 2.48% |
| COWEN AND COMPANY, LLC | 405,174 | $20,031,802 | 2.35% |
| Eschler Asset Management LLP | 60,000 | $2,966,400 | 2.34% |